ARTICLE | Company News
Management tracks
January 20, 2016 2:11 AM UTC
Drug delivery play Enteris BioPharma Inc. (Boonton, N.J.) named Joel Tune CEO and promoted Paul Shields to COO from VP of operations. Tune was Enteris' executive chairman and an independent consultant.
The Akcea Therapeutics cardiometabolic subsidiary of Ionis Pharmaceuticals Inc. (NASDAQ:IONS) named Louis O'Dea CMO. O'Dea was CMO at Oxford Immunotec Global plc (NASDAQ:OXFD). ...